Effect of portable ultrasound-guided trigger point block with levobupivacaine on myofascial pain syndrome in patients with advanced cancer
- Conditions
- myofascial pain syndrome
- Registration Number
- JPRN-UMIN000049105
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 39
Not provided
(1) Subjects taking anticoagulants or antiplatelet drugs (2) Subjects who are suggested to be prone to bleeding (3) Subjects with severe cytopenia (4) Those who are suggested to be susceptible to infection (5) Subjects with skin abnormalities such as redness, swelling, and edema at painful areas suspected of MPS (6) Subjects with chronic heart failure (7) Subjects with serious renal impairment (8) Subjects with severe liver disorder (9) Subjects who are allergic to local anesthetics (10) Subjects whose cause of the pain may be other than MPS due to bed rest (11) Body Mass Index (BMI) of 35 or more, or those who have difficulty in visualizing the muscle layer of the MPS pain site with a portable ultrasound device (12) Subjects who cannot keep quiet during the procedure (13) A person judged to have no decision-making capacity (14) Others who are judged to be inappropriate as subjects by the principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the difference in pain (NRS) on day 8 compared to pre-block
- Secondary Outcome Measures
Name Time Method (1) Difference in pain (NRS) after block on day 1 compared to pain before block on day 1 (2) Difference in pain (NRS) before block on day 4 compared to pain before block on day 1 (3) Difference in pain (NRS) after block on day 4 compared to pain before block on day 1 (4) Difference in opioid dose (oral morphine equivalent) before block on day 1 and on day 8 (5) Frequency of adverse events